METHYL 5-IODO-1H-PYRAZOLE-3-CARBOXYLATE, 95.0%, 5g

1-Bromo-4-benzyloxy-3-fluorobenzene, 97.0%, 1g

Ethyl 2-(methylsulfonyl)pyrimidine-5-carboxylate, 95.0%, 25g

1-p-Tolyl-1H-pyrazole, 95.0%, 1g

L(-)-Arabitol, min. 99%, for biochemistry, 1 g, plastic packaging.

Fmoc-(R)-3-Amino-4-(4-nitro-phenyl)-butyric acid, 97%, 1g

4-Bromo-1,1-dioxo-tetrahydro-1lambda*6*-thiophen-3-ol, 95.0%, 1g

tert-Butyl 3,3-difluoro-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 1g

Benzenesulfinic acid, 3-bromo-, sodium salt (1:1), 98%, 250mg

Pro-Pro-OH�HCl, 99.0%, 500mg

N1-(2-(dimethylamino)ethyl)-N3,N3-dimethylpropane-1,3-diamine, 98%, 250mg

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)acetamide, 95%, 100g

Mitoxantrone>95.0%(HPLC)1g